Gastroesophageal reflux (GER) in preterms: current dilemmas and unresolved problems in diagnosis and treatment

Nilgün Kültürsay1

  • 1Division of Neonatology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey. nilgun.kultursay@ege.edu.tr.

Insights

Gastroesophageal reflux (GER) is common in preterm infants, but diagnosis is challenging due to nonspecific symptoms and technical limits. Current GERD therapies lack proven efficacy and safety in this population, necessitating careful risk-benefit consideration.

Area of Science:

  • Pediatrics
  • Neonatology
  • Gastroenterology

Background:

  • Gastroesophageal reflux (GER) is a common physiological event in preterm infants.
  • Diagnosis of GER is often difficult due to nonspecific clinical signs and symptoms, as well as technical limitations.
  • Currently available GERD treatments lack proven efficacy and safety in preterm infants.

Purpose of the Study:

  • To review the challenges in diagnosing GER in preterm infants.
  • To evaluate the current understanding of GERD therapy efficacy and safety in this population.
  • To discuss preventive measures and treatment options for GERD in preterm infants.

Main Methods:

  • Literature review of studies on gastroesophageal reflux and gastroesophageal reflux disease in preterm infants.
  • Analysis of diagnostic challenges and limitations.
  • Evaluation of existing and proposed therapeutic interventions, including positioning, feeding modifications, and medical treatments.

Main Results:

  • GER is a common, yet difficult to diagnose, condition in preterm infants.
  • No current GERD treatment has demonstrated proven efficacy or safety in this population.
  • Preventive measures, such as specific infant positioning, are recommended, but require careful consideration for discharge.
  • Feeding modifications and probiotics are proposed treatments, while surgery is rarely indicated.

Conclusions:

  • Clinicians must carefully weigh the risks and benefits of GERD therapy in preterm infants.
  • Preventive strategies should be the primary approach.
  • Further systematic studies are needed to establish safe and effective GERD treatments for preterm infants.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...